Center for Infectious Disease and Immunity, The University of New Mexico Health Science Center, Albuquerque, NM, United States.
Department of Medicine, The University of New Mexico School of Medicine, Albuquerque, NM, United States.
Front Immunol. 2022 Nov 25;13:1017540. doi: 10.3389/fimmu.2022.1017540. eCollection 2022.
Human pulmonary infection with non-tuberculous mycobacteria (NTM) such as (Mabs) occurs in seemingly immunocompetent patients with underlying structural lung disease such as bronchiectasis in which normal ciliary function is perturbed. In addition to alterations in mucociliary clearance, the local immunologic milieu may be altered in patients with structural lung disease, but the nature of these changes and how they relate to NTM persistence remain unclear.
We used a mouse strain containing a conditional floxed allele of the gene , which encodes for the protein Polaris. Deletion of this gene in adult mice reportedly leads to loss of cilia on lung airway epithelium and to the development of bronchiectasis. In a series of experiments, control mice and KO mice received different preparations of lung inocula with lung CFU assessed out to approximately 8 weeks post-infection. In addition, cytokine levels in bronchoalveolar lavage (BAL) fluid, lung T cell subset analysis, and lung histopathology and morphometry were performed at various time points.
embedded in agarose beads persisted in the lungs of KO mice out to approximately 8 weeks (54 days), while agarose beads in the lungs of control mice was cleared from the lungs of all mice at this time point. T cells subset analysis showed a decrease in the percentage of CD4FoxP3 T cells in the total lymphocyte population in the lungs of KO mice relative to control mice. Proinflammatory cytokines were elevated in the BAL fluid from infected KO mice compared to infected control mice, and histopathology showed an increased inflammatory response and greater numbers of granulomas in the lungs of infected KO mice compared to the lungs of infected control mice. Scanning lung morphometry did not show a significant difference comparing lung airway area and lung airway perimeter between KO mice and control mice.
Persistent lung infection in our model was established using embedded in agarose beads. The utility of using mice is that a significant difference in lung CFU is observed comparing KO mice to control mice thus allowing for studies assessing the mechanism(s) of lung persistence. Our finding of minimal differences in lung airway area and lung airway diameter comparing KO mice to control mice suggests that the development of a proinflammatory lung phenotype in KO mice contributes to lung persistence independent of bronchiectasis. The contribution of cilia to immune regulation is increasingly recognized, and our results suggest that ciliopathy associated with structural lung disease may play a role in NTM pulmonary infection via alteration of the local immunologic lung milieu.
人类肺部感染非结核分枝杆菌(NTM),如 (Mabs),发生在看似免疫功能正常的患者中,这些患者有潜在的结构性肺病,如支气管扩张,正常的纤毛功能受到干扰。除了黏液纤毛清除功能的改变外,结构性肺病患者的局部免疫环境也可能发生改变,但这些变化的性质及其与 NTM 持续存在的关系尚不清楚。
我们使用了一种含有基因 (编码蛋白 Polaris)条件性 floxed 等位基因的小鼠品系。据报道,这种基因在成年小鼠中的缺失会导致肺气道上皮的纤毛丧失,并导致支气管扩张的发生。在一系列实验中,对照小鼠和 KO 小鼠接受了不同的 肺接种物制剂,用肺 CFU 进行评估,约 8 周后感染。此外,还在不同时间点进行了支气管肺泡灌洗液(BAL)中细胞因子水平、肺 T 细胞亚群分析、肺组织病理学和形态计量学分析。
与对照小鼠相比,KO 小鼠肺部的 琼脂糖珠持续存在约 8 周(54 天),而对照小鼠肺部的 琼脂糖珠在此时点已从所有小鼠肺部清除。T 细胞亚群分析显示,与对照小鼠相比,KO 小鼠肺部总淋巴细胞群中 CD4FoxP3 T 细胞的百分比下降。与感染对照小鼠相比,感染 KO 小鼠的 BAL 液中促炎细胞因子水平升高,组织病理学显示感染 KO 小鼠的肺部炎症反应增加,肉芽肿数量增多。扫描肺形态计量学未显示 KO 小鼠与对照小鼠之间肺气道面积和肺气道周长有显著差异。
我们使用 琼脂糖珠包埋的 建立了肺部持续感染模型。使用 KO 小鼠的优势在于,与对照小鼠相比,KO 小鼠的肺部 CFU 有显著差异,因此可以进行研究,评估 肺部持续存在的机制。我们发现 KO 小鼠与对照小鼠之间肺气道面积和肺气道直径无显著差异,这表明 KO 小鼠肺部的促炎表型的发展与支气管扩张无关,导致了 肺部持续存在。纤毛在免疫调节中的作用正日益得到认识,我们的研究结果表明,与结构性肺病相关的纤毛病可能通过改变局部免疫性肺环境在非结核分枝杆菌肺部感染中发挥作用。